155 related articles for article (PubMed ID: 32336417)
1. Cytogenetics of Blastic Plasmacytoid Dendritic Cell Neoplasm: Chromosomal Rearrangements and DNA Copy-Number Alterations.
Sakamoto K; Takeuchi K
Hematol Oncol Clin North Am; 2020 Jun; 34(3):523-538. PubMed ID: 32336417
[TBL] [Abstract][Full Text] [Related]
2. Recurrent 8q24 rearrangement in blastic plasmacytoid dendritic cell neoplasm: association with immunoblastoid cytomorphology, MYC expression, and drug response.
Sakamoto K; Katayama R; Asaka R; Sakata S; Baba S; Nakasone H; Koike S; Tsuyama N; Dobashi A; Sasaki M; Ichinohasama R; Takakuwa E; Yamazaki R; Takizawa J; Maeda T; Narita M; Izutsu K; Kanda Y; Ohshima K; Takeuchi K
Leukemia; 2018 Dec; 32(12):2590-2603. PubMed ID: 29795241
[TBL] [Abstract][Full Text] [Related]
3. An analysis of blastic plasmacytoid dendritic cell neoplasm with translocations involving the MYC locus identifies t(6;8)(p21;q24) as a recurrent cytogenetic abnormality.
Sumarriva Lezama L; Chisholm KM; Carneal E; Nagy A; Cascio MJ; Yan J; Chang CC; Cherry A; George TI; Ohgami RS
Histopathology; 2018 Nov; 73(5):767-776. PubMed ID: 29884995
[TBL] [Abstract][Full Text] [Related]
4. 8q24/MYC rearrangement is a recurrent cytogenetic abnormality in blastic plasmacytoid dendritic cell neoplasms.
Boddu PC; Wang SA; Pemmaraju N; Tang Z; Hu S; Li S; Xu J; Medeiros LJ; Tang G
Leuk Res; 2018 Mar; 66():73-78. PubMed ID: 29407586
[TBL] [Abstract][Full Text] [Related]
5. Narrowing down the common deleted region of 5q to 6.0 Mb in blastic plasmacytoid dendritic cell neoplasms.
Fu Y; Fesler M; Mahmud G; Bernreuter K; Jia D; Batanian JR
Cancer Genet; 2013; 206(7-8):293-8. PubMed ID: 24042168
[TBL] [Abstract][Full Text] [Related]
6. Molecular Features of Blastic Plasmacytoid Dendritic Cell Neoplasm: DNA Mutations and Epigenetics.
Sapienza MR; Pileri S
Hematol Oncol Clin North Am; 2020 Jun; 34(3):511-521. PubMed ID: 32336416
[TBL] [Abstract][Full Text] [Related]
7. Whole-genome analysis uncovers recurrent IKZF1 inactivation and aberrant cell adhesion in blastic plasmacytoid dendritic cell neoplasm.
Bastidas Torres AN; Cats D; Mei H; Fanoni D; Gliozzo J; Corti L; Paulli M; Vermeer MH; Willemze R; Berti E; Tensen CP
Genes Chromosomes Cancer; 2020 May; 59(5):295-308. PubMed ID: 31846142
[TBL] [Abstract][Full Text] [Related]
8. Hematopoietic Cell Transplant for Blastic Plasmacytoid Dendritic Cell Neoplasm.
Kharfan-Dabaja MA; Cherry M
Hematol Oncol Clin North Am; 2020 Jun; 34(3):621-629. PubMed ID: 32336425
[TBL] [Abstract][Full Text] [Related]
9. Genomic aberrations involving 12p/ETV6 are highly prevalent in blastic plasmacytoid dendritic cell neoplasms and might represent early clonal events.
Tang Z; Li Y; Wang W; Yin CC; Tang G; Aung PP; Hu S; Lu X; Toruner GA; Medeiros LJ; Khoury JD
Leuk Res; 2018 Oct; 73():86-94. PubMed ID: 30248580
[TBL] [Abstract][Full Text] [Related]
10. Blastic plasmacytoid dendritic cell neoplasm with immunoblastoid morphology and MYC rearrangement and overexpression.
Chang KC; Yu-Yun Lee J; Sakamoto K; Baba S; Takeuchi K
Pathology; 2019 Jan; 51(1):100-102. PubMed ID: 30482401
[No Abstract] [Full Text] [Related]
11. [Enhancer hijacking via disease-specific chromosomal translocation in blastic plasmacytoid dendritic cell neoplasm].
Kubota S
Rinsho Ketsueki; 2020; 61(1):47-51. PubMed ID: 32023603
[TBL] [Abstract][Full Text] [Related]
12. Blastic Plasmacytoid Dendritic Cell Neoplasm: Clinical Presentation and Diagnosis.
Deconinck E; Petrella T; Garnache Ottou F
Hematol Oncol Clin North Am; 2020 Jun; 34(3):491-500. PubMed ID: 32336414
[TBL] [Abstract][Full Text] [Related]
13. Lineage-specific RUNX2 super-enhancer activates MYC and promotes the development of blastic plasmacytoid dendritic cell neoplasm.
Kubota S; Tokunaga K; Umezu T; Yokomizo-Nakano T; Sun Y; Oshima M; Tan KT; Yang H; Kanai A; Iwanaga E; Asou N; Maeda T; Nakagata N; Iwama A; Ohyashiki K; Osato M; Sashida G
Nat Commun; 2019 Apr; 10(1):1653. PubMed ID: 30971697
[TBL] [Abstract][Full Text] [Related]
14. Blastic Plasmacytoid Dendritic Cell Neoplasm: The Dermatologist's Perspective.
Hirner JP; O'Malley JT; LeBoeuf NR
Hematol Oncol Clin North Am; 2020 Jun; 34(3):501-509. PubMed ID: 32336415
[TBL] [Abstract][Full Text] [Related]
15. KMT2A (MLL)-MLLT1 rearrangement in blastic plasmacytoid dendritic cell neoplasm.
Yang N; Huh J; Chung WS; Cho MS; Ryu KH; Chung HS
Cancer Genet; 2015 Sep; 208(9):464-7. PubMed ID: 26164398
[TBL] [Abstract][Full Text] [Related]
16. Immunoblastoid blastic plasmacytoid dendritic cell neoplasm with MYC rearrangement.
Yu YT; Chang KC
Blood; 2022 Apr; 139(14):2257. PubMed ID: 35389436
[No Abstract] [Full Text] [Related]
17. Blastic Plasmacytoid Dendritic Cell Neoplasm: The European Perspective.
Deconinck E
Hematol Oncol Clin North Am; 2020 Jun; 34(3):613-620. PubMed ID: 32336424
[TBL] [Abstract][Full Text] [Related]
18. Comparative genomic hybridization shows complex genomic changes of plasmacytoid urothelial carcinoma.
Keck B; Ellmann C; Stoehr R; Weigelt K; Goebell PJ; Kunath F; Taubert H; Hartmann A; Wullich B; Wach S
Urol Oncol; 2014 Nov; 32(8):1234-9. PubMed ID: 25087089
[TBL] [Abstract][Full Text] [Related]
19. Simultaneous deletion of 3'ETV6 and 5'EWSR1 genes in blastic plasmacytoid dendritic cell neoplasm: case report and literature review.
Tang Z; Tang G; Wang SA; Lu X; Young KH; Bueso-Ramos CE; Alvarado Y; Medeiros LJ; Khoury JD
Mol Cytogenet; 2016; 9():23. PubMed ID: 26925167
[TBL] [Abstract][Full Text] [Related]
20. Blastic Plasmacytoid Dendritic Cell Neoplasm.
Khoury JD
Curr Hematol Malig Rep; 2018 Dec; 13(6):477-483. PubMed ID: 30350260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
